Oscar Health, Inc.

NYSE:OSCR Lagerbericht

Marktkapitalisierung: US$3.4b

Oscar Health Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Oscar Health wird ein jährliches Gewinn- und Umsatzwachstum von 72.7% bzw. 17.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 69.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 18.3% betragen.

Wichtige Informationen

72.7%

Wachstumsrate der Gewinne

69.7%

EPS-Wachstumsrate

Insurance Gewinnwachstum10.0%
Wachstumsrate der Einnahmen17.2%
Zukünftige Eigenkapitalrendite18.3%
Analystenabdeckung

Low

Zuletzt aktualisiert07 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

May 11
Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Feb 10
Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Recent updates

Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Stock Yet As It Plummets 27%

Oct 29
Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Stock Yet As It Plummets 27%

Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Just Yet

Sep 13
Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Just Yet

Oscar Health: At Nearly 4x Book Value Investors Should Wait For A Pullback

Sep 03

Oscar Health: Achieves Profitability In Q1 2024, But Uncertainties Remain

Jul 02

Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

May 11
Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Investors Still Aren't Entirely Convinced By Oscar Health, Inc.'s (NYSE:OSCR) Revenues Despite 30% Price Jump

May 03
Investors Still Aren't Entirely Convinced By Oscar Health, Inc.'s (NYSE:OSCR) Revenues Despite 30% Price Jump

Oscar Health: Strong Industry Catalyst With Margin Expansion Potential

Apr 13

This Analyst Just Made An Upgrade To Their Oscar Health, Inc. (NYSE:OSCR) Earnings Forecasts

Feb 12
This Analyst Just Made An Upgrade To Their Oscar Health, Inc. (NYSE:OSCR) Earnings Forecasts

Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Feb 10
Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Oscar Health: Flexible Business Model Is Paying Off

Jan 30

Further Upside For Oscar Health, Inc. (NYSE:OSCR) Shares Could Introduce Price Risks After 37% Bounce

Jan 19
Further Upside For Oscar Health, Inc. (NYSE:OSCR) Shares Could Introduce Price Risks After 37% Bounce

Oscar Health, Inc. (NYSE:OSCR) Soars 49% But It's A Story Of Risk Vs Reward

Nov 21
Oscar Health, Inc. (NYSE:OSCR) Soars 49% But It's A Story Of Risk Vs Reward

Oscar Health: Q3 Earnings Suggest Growth Can Continue Into 2024

Nov 15

Oscar Health: Decreasing Memberships Is Worrying

Sep 22

Oscar Health Shares Quadrupled, But They Are Still Cheap

Jul 03

Oscar Health: High Growth And Improving Profitability Make It A Buy

Jun 15

Oscar Health Insurance GAAP EPS of -$1.05 beats by $0.03, revenue of $995M misses by $415M

Feb 09

Oscar Health: Wait For Concrete Evidence The Business Can Turn Profitable

Jan 18

Oscar Health Is Back On Track

Nov 11

Oscar Health: Improving Risk/Reward Profile To Watch

Oct 03

Florida health insurer terminating agreement with Oscar Health

Aug 30

Oscar Health Grows Revenue But Needs Progress To Profitability

Jul 08

Gewinn- und Umsatzwachstumsprognosen

NYSE:OSCR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202612,5943924815685
12/31/202511,2412093323155
12/31/20249,045187456325
9/30/20248,21529901928N/A
6/30/20247,23218253279N/A
3/31/20246,534-54-77-53N/A
12/31/20235,861-271-298-272N/A
9/30/20235,440-347-444-418N/A
6/30/20234,982-474154183N/A
3/31/20234,482-571202232N/A
12/31/20223,989-606351380N/A
9/30/20223,519-579234263N/A
6/30/20222,983-598197223N/A
3/31/20222,491-5593863N/A
12/31/20211,894-573-208-182N/A
9/30/20211,439-571-149-127N/A
6/30/20211,096-439224243N/A
3/31/2021682-406417434N/A
12/31/2020391-414209223N/A
12/31/2019476-261-191-165N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: OSCRDas prognostizierte Gewinnwachstum (72.7% pro Jahr) liegt über der Sparquote (2.6%).

Ertrag vs. Markt: OSCRDie Erträge des Unternehmens (72.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.4% pro Jahr).

Hohe Wachstumserträge: OSCREs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: OSCRDie Einnahmen des Unternehmens (17.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: OSCRDie Einnahmen des Unternehmens (17.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: OSCRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (18.3%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y